Rating Change
Wells Fargo analysts reiterated a Equal-Weight rating on Exelixis, Inc. (NASDAQ:EXEL) on July 13, 2026.
reiterateNASDAQ:EXEL
Wells Fargo Reiterates Equal-Weight Rating on Exelixis, Inc. (EXEL)
Rating Change Wells Fargo analysts reiterated a Equal-Weight rating on Exelixis, Inc. (NASDAQ:EXEL) on July 13, 2026. Market Context Exelixis, Inc.
Market Context
Exelixis, Inc. operates in the Healthcare sector. The stock currently trades at $56.04 with a market capitalization of $11.1B. The stock has gained 28.2% over the past 52 weeks.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Exelixis, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Exelixis, Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 13, 2026 | Wells Fargo | Equal-Weight | N/A |
| Jul 07, 2026 | Truist Securities | Hold | N/A |
| Jul 07, 2026 | RBC Capital | Sector Perform | N/A |
| Jul 02, 2026 | UBS | Neutral | N/A |
| Jul 02, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View EXEL Stock Page
Frequently Asked Questions
What does a Equal-Weight rating mean for EXEL?
A Equal-Weight rating from Wells Fargo reflects the analyst's outlook on Exelixis, Inc. (NASDAQ:EXEL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EXEL forecast page.